UnitedHealth Group’s Change Healthcare has fallen victim to a cyberattack, marking a credit-negative event for the company, according to Moody’s.
Category: Static
HCA cancer center shifts model for monitoring CAR-T cell therapy patients
HCA Sarah Cannon Cancer Institute in Nashville, Tenn., has introduced a model to monitor patients who received CAR-T cell therapy in an outpatient setting.
The dying art of performance reviews
Some employers are sunsetting annual performance reviews in favor of regular, daily feedback — a trend experts predict will become increasingly prevalent, The Wall Street Journal reported Feb. 22.
Identity mix-up at PeaceHealth hospital leads to wrong family's end-of-life decisions
In a case of mistaken identity, an employee of PeaceHealth Southwest Medical Center asked the wrong family to make end-of-life decisions for a patient on life support at the Vancouver, Wash.-based facility in 2021, NBC affiliate KGW reported Feb. 21.
Top healthcare jobs that pay $200K or more
Many of the top jobs that pay $200,000 or more are in healthcare, according to one new report.
Fired executive accuses Connecticut hospital of age discrimination
A former Waterbury (Conn.) Hospital executive has filed a lawsuit against her ex-employer alleging she was fired for her age, according to court documents accessed by Becker’s.
New York asks FDA to address Singulair controversy
New York Attorney General Letitia James implored the FDA Feb. 22 to update Singulair’s warning label after an uptick in pediatric mental health issues linked to the asthma and allergy drug.
ChristianaCare finds superior outcomes in Black patients
At ChristianaCare, Black patients are receiving stronger outcomes than national averages for hypertension and heart failure care.
FDA issues warning about glucose monitoring with smart devices
The FDA is warning health providers and patients to avoid use of smart devices like watches and rings that purport to measure glucose levels without piercing the skin, the agency announced Feb. 21.
Moderna expects approval of 2nd RSV shot in 1st half of 2024
Pharmaceutical giant Moderna said it anticipates initial regulatory approvals of its respiratory syncytial virus vaccine will come in the first half of 2024, according to its Q4 earnings update published Feb. 22.
